Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0247 per EA under NDC 67877056210. Its NADAC has been published 468 times since Jul 12, 2017.
Strength
850 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877056210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090564On Market Since
2/6/2017
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 468 times since Jul 12, 2017, and over the history we have for it it has declined 20.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0247 per EA |
|---|---|
| All-time high | $0.0325 (Oct 11, 2017) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0281 |
| Average price | $0.0274 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 468 |
| Tracking since | Jul 12, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0247 per EA (NDC 67877056210), effective Jun 24, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 20.6%. It has been tracked across 468 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Jul 12, 2017, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0325 (Oct 11, 2017), with a median of $0.0281 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as METFORMIN HCL 850 MG TABLET, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 67877056210) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification